JOUNCE THERAPEUTICS INC - COM (JNCE) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2017 to Q3 2023

Type / Class
Equity / COM
Symbol
JNCE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$917,823 0
2023 Q2 669,944 $917,823 -$60,999,324 $1.37 1
2023 Q1 34,310,812 $63,468,853 +$5,857,432 $1.85 83
2022 Q4 36,005,750 $39,962,925 -$13,648,332 $1.11 82
2022 Q3 42,603,434 $99,680,026 -$1,739,984 $2.34 96
2022 Q2 42,678,810 $129,316,367 -$9,423,466 $3.03 98
2022 Q1 42,306,812 $287,063,661 +$4,379,723 $6.79 109
2021 Q4 41,109,611 $342,872,903 +$7,903,036 $8.35 121
2021 Q3 36,387,318 $270,401,264 +$4,422,709 $7.43 109
2021 Q2 36,000,977 $244,796,872 -$13,671,741 $6.80 124
2021 Q1 36,831,629 $378,260,969 +$98,620,418 $10.27 118
2020 Q4 27,739,221 $194,003,698 +$12,734,175 $7.00 99
2020 Q3 25,403,035 $207,408,412 -$4,691,278 $8.16 97
2020 Q2 26,055,372 $179,734,826 -$1,739,977 $6.90 89
2020 Q1 26,402,962 $125,387,428 +$387,576 $4.75 86
2019 Q4 25,310,807 $220,536,834 +$18,778,178 $8.73 96
2019 Q3 24,077,930 $80,186,346 -$3,112,058 $3.33 75
2019 Q2 24,571,761 $121,537,224 +$164,185 $4.95 78
2019 Q1 24,732,922 $153,339,651 +$4,107,655 $6.20 78
2018 Q4 24,262,293 $81,752,172 -$11,517,176 $3.37 80
2018 Q3 27,020,094 $175,634,278 -$3,136,275 $6.50 83
2018 Q2 27,447,348 $210,249,848 -$80,817,276 $7.66 81
2018 Q1 29,417,016 $428,802,845 +$26,463,408 $22.35 92
2017 Q4 29,248,476 $372,959,190 +$6,499,719 $12.75 82
2017 Q3 15,329,891 $238,826,580 +$20,971,742 $15.58 75
2017 Q2 14,009,847 $194,609,270 +$14,846,816 $14.03 72
2017 Q1 12,662,672 $269,884,064 +$269,884,063 $21.99 59